Full-Time
Posted on 7/1/2025
Redefines healthcare delivery and access
No salary listed
Mid, Senior
Charlotte, NC, USA
In Person
Atrium Health focuses on transforming healthcare delivery to make it more accessible and compassionate. The organization aims to reach a broader audience by rethinking how care is provided, ensuring that kindness is integrated into every aspect of the health journey. Atrium Health is committed to improving health outcomes for individuals, teams, and communities, striving to ensure that everyone, regardless of their background, has the opportunity to live a healthy life. This commitment sets Atrium Health apart from its competitors, as it emphasizes a holistic approach to care and a strong focus on community well-being.
Company Size
10,001+
Company Stage
Grant
Total Funding
$30M
Headquarters
Charlotte, North Carolina
Founded
1940
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Life Insurance
Flexible Work Hours
Paid Vacation
401(k) Company Match
The PGA of America today named Atrium Health as the Official Health Care Provider and a Community Partner of the 2025 PGA Championship.
In an interview with Pharmacy Times(R) at the HOPA Annual Conference 2025, Michael Arnold, PharmD, PGY2 oncology resident at Atrium Health, emphasized the importance of biomarker testing for colorectal cancer (CRC), particularly in metastatic cases, to optimize therapy and improve patient survival rates.
Atrium Health has successfully launched the nation's first pediatric hospital-at-home (HaH) program.
Winston-Salem based digital health company is chosen as a top-10 finalist for competitive techquity program to be held at the VIVE 2025 Event in Nashville, TNWINSTON-SALEM, N.C., Jan. 23, 2025 /PRNewswire/ -- mPATH® Health, a digital health company dedicated to improving cancer screening, is proud to announce its selection as one of ten finalists in HLTH Foundation's second annual Techquity for Health Case Study Competition. This recognition highlights mPATH's dedication to providing cancer-screening services and digital health strategies to reduce outcome disparities and systemic inequities. "We initially developed mPATH at Wake Forest University School of Medicine to overcome literacy barriers in healthcare. A digital program can use animations and graphics to convey a message whereas health professionals can only use their words," says Dr. David Miller, mPATH inventor and founder of mPATH Health
"The selected recipients exemplify excellence in research and clinical care, and we are confident that the TORCH Initiative will drive meaningful advancements in the fight against rare pediatric cancers." Nilay Shah, Chair of the Scientific Committee. Post thisA highly esteemed scientific committee, composed of leading experts in pediatric oncology, was convened to review over 16 RFPs submitted by the 14 hospitals invited to submit for the TORCH Initiative. The committee meticulously evaluated each proposal based on criteria including innovation, feasibility, and the potential to advance both basic science and clinical practices in pediatric oncology."We were overwhelmed by the quality and diversity of the proposals submitted," said Nilay Shah, Chair of the Scientific Committee. "The selected recipients exemplify excellence in research and clinical care, and we are confident that the TORCH Initiative will drive meaningful advancements in the fight against rare pediatric cancers."Each of the selected hospitals will use the TORCH Initiative funding to further their efforts in critical areas of pediatric cancer research and treatment.Novant Health ( Charlotte, NC ): Funding will support two initiatives for children with rare pediatric cancers, providing essential mental health services for patients and families and nutrient-rich meals to enhance healing and improve quality of life.): Funding will support two initiatives for children with rare pediatric cancers, providing essential mental health services for patients and families and nutrient-rich meals to enhance healing and improve quality of life. Duke University School of Medicine ( Durham, NC ): In partnership with Atrium Health, funding will be utilized to improve osteosarcoma treatment by evaluating higher methotrexate thresholds for discharge, potentially reducing hospital stays and costs while maintaining safety. Additionally, it explores the use of organoids to study tumor resistance and identify new therapeutic opportunities.School of Medicine ( ): In partnership with Atrium Health, funding will be utilized to improve osteosarcoma treatment by evaluating higher methotrexate thresholds for discharge, potentially reducing hospital stays and costs while maintaining safety